Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Ritlecitinib bulk supplier for pharma manufacturers

Ritlecitinib 50 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 50 mg

Reference Brands: Litfulo (USA/EU)

Category: Immune Disorder

Ritlecitinib is used to treat severe alopecia areata. It works as a selective JAK3/TEC family kinase inhibitor that helps reduce immune-mediated hair follicle damage, supporting hair regrowth in patients with autoimmune-related hair loss. It is taken orally once daily.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Ritlecitinib — third party manufacturing & bulk supply

Ritlecitinib 50 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ritlecitinib is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ritlecitinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ritlecitinib →
Back to Listing

Frequently Asked Questions

Ritlecitinib is used to treat severe alopecia areata, an autoimmune condition that causes hair loss.

Ritlecitinib is a small molecule that selectively inhibits Janus kinase 3 (JAK3) and tyrosine kinase expressed in hepatocellular carcinoma (TEC) family kinases.

The trade name is Litfulo.

Litfulo is made by Pfizer.

The generic name is ritlecitinib.

The brand name is Litfulo.

It is manufactured in the United States by Pfizer.

Related Products

Etrasimod Arginine

Strength:
2 mg, 4 mg, 6 mg

Form: Tablets

Reference Brands: Velsipity (USA)

View Details
Avacopan

Strength:
10 mg

Form: Capsules

Reference Brands: Tavneos (USA/EU)

View Details
Fostamatinib Disodium

Strength:
100 mg, 150 mg

Form: Tablets

Reference Brands: Tavalisse (USA)

View Details
Deucravacitinib

Strength:
6 mg

Form: Tablet

Reference Brands: Sotyktu (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.